| Ticker Details |
Emergent Biosolutions, Inc.
Emergent BioSolutions Inc is a biotechnology company operating in two divisions: biodefense and biosciences. The company focuses on countermeasures that address public health threats around hematology and oncology therapeutics.
|
| IPO Date: |
December 1, 2006 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$436.4M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.57 | 2.30%
|
| Avg Daily Range (30 D): |
$0.15 | 1.79%
|
| Avg Daily Range (90 D): |
$0.22 | 2.06%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.56M |
| Avg Daily Volume (30 D): |
.87M |
| Avg Daily Volume (90 D): |
.71M |
| Trade Size |
| Avg Trade Size (Sh.): |
109 |
| Avg Trade Size (Sh.) (30 D): |
63 |
| Avg Trade Size (Sh.) (90 D): |
63 |
| Institutional Trades |
| Total Institutional Trades: |
5,060 |
| Avg Institutional Trade: |
$2.48M |
| Avg Institutional Trade (30 D): |
$1.32M |
| Avg Institutional Trade (90 D): |
$1.42M |
| Avg Institutional Trade Volume: |
.08M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.13M |
| Avg Closing Trade (30 D): |
$1.32M |
| Avg Closing Trade (90 D): |
$1.29M |
| Avg Closing Volume: |
109.18K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$.98
|
$-1.01
|
$.98
|
|
Diluted EPS
|
$.93
|
$-.96
|
$.93
|
|
Revenue
|
$742.9M
|
$148.7M
|
$742.9M
|
|
Gross Profit
|
$416.7M
|
$63.8M
|
$416.7M
|
|
Net Income / Loss
|
$52.6M
|
$-54.6M
|
$52.6M
|
|
Operating Income / Loss
|
$100.1M
|
$-27.9M
|
$100.1M
|
|
Cost of Revenue
|
$326.2M
|
$84.9M
|
$326.2M
|
|
Net Cash Flow
|
$103.5M
|
$-40.1M
|
$103.5M
|
|
PE Ratio
|
8.56
|
|
|
|
|
|
